Many studies have shown that the existing antidiabetic drug thiazolidinediones (TZDs), also a synthetic agonists of PPAR‐γ, exert a beneficial effect on breast cancer treatment in both a pre‐clinical mouse models and clinical trials.49 Here, PPARG is linked to breast cancer.